The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOOTPATH: A randomized, open-label phase-2 study of liposomal irinotecan + 5-FU and folinic acid (NAPOLI) versus sequential NAPOLI and mFOLFOX6 versus gemcitabine/nab-paclitaxel in treatment-naïve metastatic pancreatic cancer (mPDAC).
 
Benedikt Westphalen
Honoraria - Bayer; GlaxoSmithKline; Ipsen; Merck Serono; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - BMS; Celgene; MSD; Rafael Pharmaceuticals; RedHill Biopharma; Roche; Shire
Research Funding - Boehringer Ingelheim (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Bayer; Celgene; Halozyme; RedHill Biopharma; Roche; SERVIER; Taiho Pharmaceutical
 
Tobias Gaska
No Relationships to Disclose
 
Maximilian Reichert
Honoraria - Celgene; Roche
 
Michael Quante
Honoraria - Servier
Consulting or Advisory Role - Servier
 
Helmut Oettle
No Relationships to Disclose
 
Dirk Thomas Waldschmidt
Speakers' Bureau - AstraZeneca; Bayer/Vital; Bayer/Vital; Eisai Germany; Incyte; Ipsen; MSD Oncology; Roche Pharma AG; SERVIER
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Lilly; SERVIER
 
Anke Schlenska-Lange
No Relationships to Disclose
 
Stefan Angermeier
No Relationships to Disclose
 
Ludwig Fischer von Weikersthal
Honoraria - Lilly O.; Pierre Fabre
 
Wolfram Bohle
No Relationships to Disclose
 
Ursula Vehling-Kaiser
No Relationships to Disclose
 
Arndt Stahler
Honoraria - Roche; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Novocure
Travel, Accommodations, Expenses - Amgen; Lilly; Pfizer; Roche
 
Stephan Kanzler
No Relationships to Disclose
 
Christof Lamberti
No Relationships to Disclose
 
Uwe Pelzer
No Relationships to Disclose
 
Marianne Sinn
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Pfizer; Pierre Fabre; SERVIER
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck Sharp & Dohme; Pierre Fabre; Roche; SERVIER
 
Wolfgang Blau
No Relationships to Disclose
 
Stefan Hubert Boeck
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene; Incyte; Janssen-Cilag; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Incyte; Janssen-Cilag; Merck Sharp & Dohme; SERVIER
Research Funding - Celgene
 
Swantje Held
No Relationships to Disclose
 
Volker Heinemann
Honoraria - Amgen; AstraZeneca; Merck; MSD; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD; MSD Oncology; Nordic Bioscience; Novartis; Oncosil; Pierre Fabre; Roche; Servier/Pfizer; TERUMO
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merck